… We examined the association between hydroxychloroquine use and respiratory failure at a
… of patients with Covid-19 in New York City. We hypothesized that hydroxychloroquine use …

… in patients hospitalized with Covid-19, we randomly assigned 1561 patients to receive
hydroxychloroquine and 3155 to receive usual care. The primary outcome was 28-day mortality. …

… shedding patterns in infected patients differ substantially, making covid-19’s more similar to
… load of covid-19 has been similar in asymptomatic patients and symptomatic patients, thus, …

… number of patients with COVID‐19 are treated … use in the treatment of auto‐immune conditions,
and provided a component in the original rationale for their use in patients with COVID‐19…

… ” OR “clinical recovery” AND COVID-19 OR SARS-CoV-2. We retrieved all the studies
conducted with hydroxychloroquine in patients with COVID-19 that was compared to control, and …

… ) issued an EUA to allow hydroxychloroquine sulfate and chloroquine phosphate donated
to … and used for hospitalized COVID-19 patients. In fact, these two drugs have been used for …

… We prospectively enrolled 30 treatment-naïve patients with confirmed COVID-19 after …
The patients were randomized 1:1 to HCQ group and the control group. Patients in HCQ group …

… 62 patients were identified as having COVID-19 and enrolled in this study, none quit (Figure
1). As shown in Table 1, For all patients, … Patients were randomly assigned into two groups. …

… agents for early COVID-19 in nonhospitalized patients. … Hydroxychloroquine use in patients
with COVID-19 has a low a … do not support the use of hydroxychloroquine in early COVID-19. …

… the use of hydroxychloroquine in hospitalized patients with this … or hydroxychloroquine in
hospitalized patients with Covid-19. … no benefit of hydroxychloroquine for either postexposure …